Health Blueprint

Back to Longevity News

News summary

Superpower launches peptide program tied to blood testing

Source: Longevity Technology • Published: 03 Nov 2026, 09:31

Summarized by Masters of Longevity from Longevity Technology.

Company will offer compounded peptides with clinician evaluation and lab monitoring.

Superpower launches peptide program tied to blood testing
Key Takeaways
  • Program is for members after clinician evaluation and intake.
  • Initial peptides are BPC-157, TB-500 and MOTS-C.
  • Safety and effectiveness in humans remain limited and unproven.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.